Gaming giant Aristocrat has settled a suit brought against its former head of design, who admitted to copying a “substantial” number of documents containing the company’s sensitive trade secrets.
Aristocrat has asked the High Court to rule once and for all on whether its popular Lightning Link game is patentable, after a differently comprised court was evenly split on the question.
IP Australia has rejected AFT Pharmaceuticals’ bid to patent a combination cold and flu medication, finding the invention was little more than putting three different medications “in a box”.
Aristocrat has sued competitor Light & Wonder and two former employees for allegedly using confidential information about its popular Dragon Link poker game to develop a competing product.
Fortescue has defeated a bid by its former CFO’s green iron start-up to set aside search orders that were said to have been secured “off the back of egregious material non-disclosure”.
US drug giant Eli Lilly cannot register a trade mark consisting of the word ‘hair’ preceded by the ‘greater-than’ symbol, despite winning registration in the UK, Switzerland and New Zealand.
The developer of the blockbuster horror video game Dead by Daylight has succeeded in revoking the trade mark of rival developer of a virtual sporting game.
A founder and former principal at a Sydney intellectual property firm has made the switch to Dentons, filling out the firm’s Australasian patents team.
Samsung Bioepis can’t get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug.
The developer of a Canola seed hybrid tolerant to herbicide has lost a bid for seed grower Nuseed to relabel its products, which are already stocked in 361 retail locations.